关于我们 服务 接触
 

Nanosecond PFA Advantage

Nanosecond PFA Advantage

The company’s recent multicenter review reported encouraging 6‑ and 12‑month follow‑up results from a feasibility study using the nPulse Cardiac Catheter. Preclinical work also demonstrated that nanosecond PFA generates substantially deeper tissue lesions than microsecond pulses, underscoring the technology’s therapeutic advantage.
04/02/2026 | Pulse Biosciences, Inc.